7130.Full.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Load more

The Journal of Neuroscience, August 15, 1999, 19(16):7130–7139 Changes in Neuropeptide Y Receptors and Pro-Opiomelanocortin in the Anorexia (anx/anx) Mouse Hypothalamus Christian Broberger,1 Jeanette Johansen,2 Hjalmar Brismar,3 Carolina Johansson,2 Martin Schalling,2 and Tomas Ho¨ kfelt1 Departments of 1Neuroscience, 2Molecular Medicine, and 3Woman and Child Health, Karolinska Institutet, 171 77 Stockholm, Sweden The pro-opiomelanocortinergic (POMCergic) system originating NPY Y1 and Y5 receptors, which are expressed in POMC in the hypothalamic arcuate nucleus extends projections widely neurons, were decreased. Also, expression of the NPY Y2 over the brain and has been shown to be intricately linked and autoreceptor was attenuated. Immunohistochemistry using an- parallel to the arcuate neuropeptide Y (NPY) system. Both NPY tibodies against adrenocorticotropic hormone to demonstrate and POMC-derived peptides (melanocortins) have been POMC cell bodies, against a-melanocyte-stimulating hormone strongly implicated in the control of feeding behavior, with the to demonstrate axonal projections and against the NPY Y1 former exerting orexigenic effects and the latter having anorex- receptor to demonstrate dendritic arborizations, showed strik- igenic properties. Mice homozygous for the lethal anorexia (anx) ingly decreased immunoreactivities for all these markers. The mutation are hypophagic, emaciated, and exhibit anomalous present data suggest that degeneration of the arcuate POMC processing of NPY exclusively in the arcuate nucleus, providing system is a feature characteristic of the anx/anx mouse. The an interesting model to study NPY–POMC interactions. In the possible relationship to the NPYergic phenotype of this animal present study, several morphological markers were used to is discussed. investigate the histochemistry and morphology of the POMC Key words: adrenocorticotropic hormone; a-melanocyte- system in anx/anx mice. In situ hybridization demonstrated stimulating hormone; arcuate nucleus; feeding; immunohisto- decreased numbers of POMC mRNA-expressing neurons in the chemistry; in situ hybridization; paraventricular nucleus of the anx/anx arcuate nucleus. In parallel, mRNA levels for both the hypothalamus; trophism The neurochemical basis for the central control of food intake has The projections of the arcuate NPY and POMC neurons follow been illuminated by recent investigations (Leibowitz, 1995; seemingly parallel routes (Broberger et al., 1998b) and may ter- Sawchenko, 1998; Woods et al., 1998; Elmquist et al., 1999; Kalra minate on common postsynaptic targets. NPY neurons also in- et al., 1999). Two messenger molecules expressed in discrete nervate the POMC cell bodies, which express the inhibitory NPY populations of the hypothalamic arcuate nucleus appear to play Y1 receptor (Y1R) (Csiffa´ry et al., 1990; Zhang et al., 1994; antagonistic roles in energy balance control, namely neuropeptide Broberger et al., 1997b; Fuxe et al., 1997). A similar expression Y (NPY) (Tatemoto, 1982; Tatemoto et al., 1982) and pro- pattern has been suggested for the Y5 receptor (Y5R) (Gerald et opiomelanocortin (POMC) (Mains et al., 1977; Roberts and Her- al., 1996; Naveilhan et al., 1998a). Activation of the Y1R and the bert, 1977; Nakanishi et al., 1979), the precursor protein for the Y5R (Flood and Morley, 1989; Stanley et al., 1992; Gerald et al., melanocortin peptides adrenocorticotropic hormone (ACTH) 1996) stimulates food intake, possibly through inhibition of a a and -melanocyte-stimulating hormone ( -MSH). Intracerebral POMC signaling. In addition, NPY neurons also express agouti injections of NPY stimulate food intake (Clark et al., 1984; gene-related protein (AGRP) (Shutter et al., 1997; Broberger et Stanley and Leibowitz, 1985), whereas melanocortin treatment al., 1998a,b; Hahn et al., 1998), an antagonist of the melanocortins induces anorexia (Poggioli et al., 1986; Fan et al., 1997; Grill et (Ollmann et al., 1997). Thus, both anatomical and pharmacolog- al., 1998), and mice deficient for the melanocortin-4 receptor ical evidence suggest that the balance between NPY and POMC develop obesity (Huszar et al., 1997). Furthermore, fasting in- transmission may be correlated to the level of food intake. creases arcuate NPY mRNA levels and decreases POMC mRNA The anorexia (anx) mutation is a recessive autosomal mutation (Brady et al., 1990). in mice that phenotypically results in decreased food intake, emaciation, and premature death during the fourth postnatal week (Maltais et al., 1984). A possible explanation for this phe- Received Feb. 11, 1999; revised April 28, 1999; accepted June 3, 1999. notype was provided by the recent demonstration of NPY abnor- This study was supported by the Swedish Medical Research Council (Grants malities in anx/anx mice that appear to be restricted to the arcuate 14X-2887 and 13X-10909 for T.H. and M.S., respectively), Marianne and Marcus Wallenberg’s Foundation, a Bristol-Myers Squibb Unrestricted Neuroscience grant system, characterized by a decrease in the number of its NPY- to T.H., National Alliance for Research on Schizophrenia and Depression, and immunoreactive (-IR) nerve terminals and a strongly increased funds from Karolinska Institutet and the Karolinska Hospital. We thank Drs. John Walsh and Helen Wong, (CURE, University of California at Los Angeles, Los perikaryal staining in the arcuate nucleus, a pattern suggestive Angeles, CA) for kindly providing Y1 receptor antiserum (antibody/Radioimmu- of cell body accumulation and impaired transport and/or release noassay Core Grant DK41301). (Broberger et al., 1997a). The same pattern was also noted with Correspondence should be addressed to Dr. Christian Broberger, Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden. AGRP histochemistry (Broberger et al., 1998b). In accordance Copyright © 1999 Society for Neuroscience 0270-6474/99/197130-10$05.00/0 with the orexigenic function of arcuate NPY neurons described Broberger et al. • Arcuate POMC in anx/anx Mice J. Neurosci., August 15, 1999, 19(16):7130–7139 7131 above, diminished NPY–AGRP signaling could be causally re- in distilled water, exposed for 1 (POMC probe) or 8 (Y1R, Y2R, and 2 lated to the anorectic phenotype of anx/anx mice. Y5R probes) weeks in light-free metal containers at 20°C, developed in Kodak D19 for 3 min, and fixed in Kodak 3000 for 6–7 min. Sections The present study investigated the histochemistry of POMC were rinsed in distilled water, counterstained with cresyl violet, and neurons in anx/anx mice, using several markers expressed by this coverslipped with Entellan (Merck). All sections were examined under population, to gain understanding of how the melanocortinergic bright- and dark-field illumination using a Nikon (Tokyo, Japan) system functions in a potentially “hypoNPYergic” state. These Microphot-FX microscope. Photomicrographs were taken with Kodak markers include mRNAs for POMC, the Y1R and the Y5R T-max 100 film. a Quantification of autoradiograms. Measurements were performed on a studied by in situ hybridization, as well as ACTH, -MSH, and MacIntosh IIx (Apple Computer Inc., Cupertino, CA) equipped with a the Y1R studied by immunohistochemistry. We have also inves- Quick Capture frame grabber card (Data Translation, Marlboro, MA), tigated the expression of the autoinhibitory Y2 receptor coex- a Northern Light precision illuminator (Imaging Research, St. Ca- pressed with NPY in arcuate neurons (Broberger et al., 1997b) in tharines, Ontario, Canada), and a Dage-MTI CCD-72 series camera anx/anx mice. (Dage-MTI, Michigan City, IN) equipped with a Nikon 55 mm lens. To process images, NIH Image software (courtesy of Wayne Rasband, Part of these results have been presented previously in abstract National Institute of Mental Health, Bethesda, MD) was used. Each form (Broberger et al., 1998c). image was an average of eight video frames digitized to a 512 3 512 matrix with 256 gray levels for each picture element. To adjust for MATERIALS AND METHODS possible defect in the illumination or optical pathway, an image of the empty illumination screen was taken through a neutral filter and used for Animals. Animals were housed together in ventilated cages in an animal background shading correction. The gray levels of eight 14C-plastic room maintained on a 12 hr light/dark schedule with lights on at 7.00 standards (Amersham) (Miller, 1991) exposed to the autoradiography A.M., at a temperature of 125°C. The anx/anx mice were characterized film together with the tissue sections were determined and used in a genotypically using nearby located simple sequence length polymor- third-degree polynominal approximation to construct a gray level to phisms and phenotypically on the basis of body weight and neurological abnormalities determined before dissection–perfusion. Both male and activity transfer function. The borders of the measuring fields were female mice were analyzed. For in situ hybridization, 10 anx/anx mice interactively defined, and the average gray level was calculated using the and eight wild-type littermates were used. For immunohistochemistry, Macintosh computer and Microsoft Excel (Apple). The average gray six anx/anx mice and seven wild-type littermates were used. Dissection level of control tissue was set to 100%, and changes in gray levels in the was performed on postnatal days 20 or 21. For in situ hybridization arcuate nucleus from sections of anx/anx mice were expressed as per- experiments, brains were dissected from decapitated animals and rapidly
Recommended publications
  • One-Month of High-Intensity Exercise Did Not Change the Food Intake And

    One-Month of High-Intensity Exercise Did Not Change the Food Intake And

    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/ by-nc-nd/3.0), which permits copy and redistribute the material in any medium or format, provided the original work is properly cited. 8 ENDOCRINE REGULATIONS, Vol. 53, No. 1, 8–13, 2019 doi:10.2478/enr-2019-0002 One-month of high-intensity exercise did not change the food intake and the hypothalamic arcuate nucleus proopiomelanocortin and neuropeptide Y expression levels in male Wistar rats Nazli Khajehnasiri1, Homayoun Khazali2, Farzam Sheikhzadeh3, Mahnaz Ghowsi4 1Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran; 2Department of Animal Sciences and Biotechnology, Faculty of Biological Sciences and Technology, Shahid Beheshti University, Tehran, Iran; 3Department of Animal Sciences, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran; 4Department of Biology, Faculty of Sciences, Razi University, Kermanshah, Iran E-mail: [email protected] Objective. The hypothalamic arcuate nucleus proopiomelanocortin (POMC) and neuropeptide Y (NPY) circuitries are involved in the inhibition and stimulation of the appetite, respectively. The aim of this study was to investigate the effects of one-month lasting high-intensity exercise on the POMC mRNA and NPY mRNA expression in the above-mentioned brain structure and appetite and food intake levels. Methods. Fourteen male Wistar rats (250±50 g) were used and kept in the well-controlled con- ditions (22±2 °C, 50±5% humidity, and 12 h dark/light cycle) with food and water ad libitum. The rats were divided into two groups (n=7): 1) control group (C, these rats served as controls) and 2) exercised group (RIE, these rats performed a high-intensity exercise for one month (5 days per week) 40 min daily with speed 35 m/min.
  • CCK-8S) of Protein Phosphorylation in the Neostriatum (Forskonln/N-Methyl-D-Aspartic Acid/Glutamate) GRETCHEN L

    CCK-8S) of Protein Phosphorylation in the Neostriatum (Forskonln/N-Methyl-D-Aspartic Acid/Glutamate) GRETCHEN L

    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 11277-11281, December 1993 Neurobiology Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum (forskonln/N-methyl-D-aspartic acid/glutamate) GRETCHEN L. SNYDER*, GILBERTO FISONE*, PATRIZIA MORINOt, VIDAR GUNDERSEN*, OLE PETTER OTTERSEN*, TOMAS HOKFELTt, AND PAUL GREENGARD*§ *Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, NY 10021; tDepartment of Histology and Neurobiology, Karolinska Institute, S-10401, Stockholm, Sweden; and *Department of Anatomy, University of Oslo, Blindern, N-0317 Oslo, Norway Contributed by Tomas Hokfelt, August 16, 1993 ABSTRACT Despite physiological evidence that cholecys- rons, apparently through a mechanism that involves the tokinin (CCK) is an excitatory neurotransmitter in the brain, release of an excitatory neurotransmitter and activation of little is known about its mechanism of action. CCK immuno- NMDA receptors. reactivity in the brain, including projections to the striatum, is primarily attributable to the sulfated octapeptide CCK-8S. We report here that CCK-8S abolishes cAMP-dependent phos- MATERIALS AND METHODS phorylation ofa dopamine- and cAMP-regulated 32-kDa phos- Materials. RPMI 1640 balanced salt solution, bovine serum phoprotein (DARPP-32) in striatal neurons. The effect of albumin, and 3-isobutylmethylxanthine were obtained from CCK-8S is prevented by antagonists of CCKB and N-methyl- Sigma; forskolin was from Calbiochem; NMDA and (+)-MK- D-aspartate receptors. Our results support a model in which 801 hydrogen maleate (MK-801) were from Research Bio- CCK-8S, originating from CCK or CCK/glutamate cortico- chemicals; CCK-8S was from Bachem; CI-988 was from J. striatal neurons, promotes the release of an excitatory neuro- Hughes; cAMP, RIA, and ECL Western blotting detection transmitter that causes the dephosphorylation and inactivation kits were from Amersham; and goat anti-mouse horseradish of DARPP-32, a potent protein phosphatase inhibitor, thereby peroxidase-linked antibody was from Pierce.
  • Dietary Fat Alters the Response of Hypothalamic Neuropeptide Y to Subsequent Energy Intake in Broiler Chickens Xiao J

    Dietary Fat Alters the Response of Hypothalamic Neuropeptide Y to Subsequent Energy Intake in Broiler Chickens Xiao J

    © 2017. Published by The Company of Biologists Ltd | Journal of Experimental Biology (2017) 220, 607-614 doi:10.1242/jeb.143792 RESEARCH ARTICLE Dietary fat alters the response of hypothalamic neuropeptide Y to subsequent energy intake in broiler chickens Xiao J. Wang, Shao H. Xu, Lei Liu, Zhi G. Song, Hong C. Jiao and Hai Lin* ABSTRACT Several studies have shown that these hypothalamic neuropeptides Dietary fat affects appetite and appetite-related peptides in birds and are sensitive to body energy status and critical to whole-body mammals; however, the effect of dietary fat on appetite is still unclear metabolic adjustment. NPY reduces energy expenditure by in chickens faced with different energy statuses. Two experiments decreasing adipose tissue thermogenesis (Egawa et al., 1991; Patel were conducted to investigate the effects of dietary fat on food intake et al., 2006; Chao et al., 2011; Zhang et al., 2014). The obesity of and hypothalamic neuropeptides in chickens subjected to two ob/ob mice is attenuated when NPY is knocked out (Erickson et al., fi feeding states or two diets. In Experiment 1, chickens were fed a 1996; Segal-Lieberman et al., 2003). NPY de ciency attenuates high-fat (HF) or low-fat (LF) diet for 35 days, and then subjected to fed responses to a palatable high fat diet in mice (Hollopeter et al., 1998; (HF-fed, LF-fed) or fasted (HF-fasted, LF-fasted) conditions for 24 h. Patel et al., 2006). Animals in which POMC neurons have been In Experiment 2, chickens that were fed a HF or LF diet for 35 days knocked out are obese and hyperphagic (Butler and Cone, 2002; were fasted for 24 h and then re-fed with HF (HF-RHF, LF-RHF) or LF Mencarelli et al., 2012; Diané et al., 2014; Raffan et al., 2016).
  • Neuropeptide Y in the Amygdala Induces Long-Term

    Neuropeptide Y in the Amygdala Induces Long-Term

    The Journal of Neuroscience, January 23, 2008 • 28(4):893–903 • 893 Behavioral/Systems/Cognitive Neuropeptide Y in the Amygdala Induces Long-Term Resilience to Stress-Induced Reductions in Social Responses But Not Hypothalamic–Adrenal–Pituitary Axis Activity or Hyperthermia Tammy J. Sajdyk,1 Philip L. Johnson,1 Randy J. Leitermann,3 Stephanie D. Fitz,1 Amy Dietrich,1 Michelle Morin,2 Donald R. Gehlert,2 Janice H. Urban,3 and Anantha Shekhar1 1Institute of Psychiatric Research, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202, 2Eli Lilly, Indianapolis, Indiana 46201, and 3Department of Physiology and Biophysics and Interdepartmental Neurosciences Program, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois 60064 Resilience to mental and physical stress is a key determinant for the survival and functioning of mammals. Although the importance of stress resilience has been recognized, the underlying neural mediators have not yet been identified. Neuropeptide Y (NPY) is a peptide known for its anti-anxiety-like effects mediated via the amygdala. The results of our current study demonstrate, for the first time that repeated administration of NPY directly into the basolateral nucleus of the amygdala (BLA) produces selective stress-resilient behavioral responses to an acute restraint challenge as measured in the social interaction test, but has no effect on hypothalamic–adrenal–pituitary axisactivityorstress-inducedhyperthermia.Moreimportantly,theresilientbehaviorsobservedintheNPY-treatedanimalswerepresent for up to 8 weeks. Antagonizing the activity of calcineurin, a protein phosphatase involved in neuronal remodeling and present in NPY receptor containing neurons within the BLA, blocked the development of long-term, but not the acute increases in social interaction responses induced by NPY administration.
  • Neuropeptides Controlling Energy Balance: Orexins and Neuromedins

    Neuropeptides Controlling Energy Balance: Orexins and Neuromedins

    Neuropeptides Controlling Energy Balance: Orexins and Neuromedins Joshua P. Nixon, Catherine M. Kotz, Colleen M. Novak, Charles J. Billington, and Jennifer A. Teske Contents 1 Brain Orexins and Energy Balance ....................................................... 79 1.1 Orexin............................................................................... 79 2 Orexin and Feeding ....................................................................... 80 3 Orexin and Arousal ....................................................................... 83 J.P. Nixon • J.A. Teske Veterans Affairs Medical Center, Research Service (151), Minneapolis, MN, USA Department of Food Science and Nutrition, University of Minnesota, 1334 Eckles Avenue, St. Paul, MN 55108, USA Minnesota Obesity Center, University of Minnesota, 1334 Eckles Avenue, St. Paul, MN 55108, USA C.M. Kotz (*) Veterans Affairs Medical Center, GRECC (11 G), Minneapolis, MN, USA Veterans Affairs Medical Center, Research Service (151), Minneapolis, MN, USA Department of Food Science and Nutrition, University of Minnesota, 1334 Eckles Avenue, St. Paul, MN 55108, USA Minnesota Obesity Center, University of Minnesota, 1334 Eckles Avenue, St. Paul, MN 55108, USA e-mail: [email protected] C.M. Novak Department of Biological Sciences, Kent State University, Kent, OH, USA C.J. Billington Veterans Affairs Medical Center, Research Service (151), Minneapolis, MN, USA Veterans Affairs Medical Center, Endocrine Unit (111 G), Minneapolis, MN, USA Department of Food Science and Nutrition, University of Minnesota, 1334 Eckles Avenue, St. Paul, MN 55108, USA Minnesota Obesity Center, University of Minnesota, 1334 Eckles Avenue, St. Paul, MN 55108, USA H.-G. Joost (ed.), Appetite Control, Handbook of Experimental Pharmacology 209, 77 DOI 10.1007/978-3-642-24716-3_4, # Springer-Verlag Berlin Heidelberg 2012 78 J.P. Nixon et al. 4 Orexin Actions on Endocrine and Autonomic Systems ................................. 84 5 Orexin, Physical Activity, and Energy Expenditure ....................................
  • Evolution of the Neuropeptide Y and Opioid Systems and Their Genomic

    Evolution of the Neuropeptide Y and Opioid Systems and Their Genomic

    It's time to try Defying gravity I think I'll try Defying gravity And you can't pull me down Wicked List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I Sundström G, Larsson TA, Brenner S, Venkatesh B, Larham- mar D. (2008) Evolution of the neuropeptide Y family: new genes by chromosome duplications in early vertebrates and in teleost fishes. General and Comparative Endocrinology Feb 1;155(3):705-16. II Sundström G, Larsson TA, Xu B, Heldin J, Lundell I, Lar- hammar D. (2010) Interactions of zebrafish peptide YYb with the neuropeptide Y-family receptors Y4, Y7, Y8a and Y8b. Manuscript III Sundström G, Xu B, Larsson TA, Heldin J, Bergqvist CA, Fredriksson R, Conlon JM, Lundell I, Denver RJ, Larhammar D. (2010) Characterization of the neuropeptide Y system's three peptides and six receptors in the frog Silurana tropicalis. Manu- script IV Dreborg S, Sundström G, Larsson TA, Larhammar D. (2008) Evolution of vertebrate opioid receptors. Proc Natl Acad Sci USA Oct 7;105(40):15487-92. V Sundström G, Dreborg S, Larhammar D. (2010) Concomitant duplications of opioid peptide and receptor genes before the origin of jawed vertebrates. PLoS One May 6;5(5):e10512. VI Sundström G, Larsson TA, Larhammar D. (2008) Phylogenet- ic and chromosomal analyses of multiple gene families syntenic with vertebrate Hox clusters. BMC Evolutionary Biology Sep 19;8:254. VII Widmark J, Sundström G, Ocampo Daza D, Larhammar D. (2010) Differential evolution of voltage-gated sodium channels in tetrapods and teleost fishes.
  • Rfamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential

    Rfamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential

    Pharmaceuticals 2011, 4, 1248-1280; doi:10.3390/ph4091248 OPEN ACCESS Pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential Maria Findeisen †, Daniel Rathmann † and Annette G. Beck-Sickinger * Institute of Biochemistry, Leipzig University, Brüderstraße 34, 04103 Leipzig, Germany; E-Mails: [email protected] (M.F.); [email protected] (D.R.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-341-9736900; Fax: +49-341-9736909. Received: 29 August 2011; in revised form: 9 September 2011 / Accepted: 15 September 2011 / Published: 21 September 2011 Abstract: Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological functions, like important neuroendocrine, behavioral, sensory and automatic functions. The RFamide peptide receptor family represents a multiligand/multireceptor system, as many ligands are recognized by several GPCR subtypes within one family. Multireceptor systems are often susceptible to cross-reactions, as their numerous ligands are frequently closely related. In this review we focus on recent results in the field of structure-activity studies as well as mutational exploration of crucial positions within this GPCR system. The review summarizes the reported peptide analogs and recently developed small molecule ligands (agonists and antagonists) to highlight the current understanding of the pharmacophoric elements, required for affinity and activity at the receptor family.
  • Calcitonin Gene-Related Peptide and Other Peptides

    Calcitonin Gene-Related Peptide and Other Peptides

    P1: KWW/KKL P2: KWW/HCN QC: KWW/FLX T1: KWW GRBT050-16 Olesen- 2057G GRBT050-Olesen-v6.cls July 9, 2005 4:30 ••Chapter 16 ◗ Calcitonin Gene-Related Peptide and Other Peptides Susan Brain and Lars Edvinsson Vasoactive peptides can be either stored or synthesized de THE CGRP FAMILY OF PEPTIDES novo before release from a range of tissues in the brain or from the walls of intracranial vasculature. In this chapter, The expression of mRNA from the calcitonin gene is tissue we concentrate on neuropeptides that are released from specific in that CGRP mRNA is predominantly expressed perivascular nerves. These include calcitonin gene-related in nerves and calcitonin mRNA in the thyroid (5). The 37 peptide (CGRP), substance P, neurokinin A, nociceptin, amino acid peptide CGRP belongs to a family that include somatostatin, and opioids (Table 16-1). The endothelium the more recently discovered peptides adrenomedullin produces the potent vasoconstrictors endothelin and an- that is primarily produced by non-neuronal tissues, espe- giotensin, and dilators such as nitric oxide, prostacyclin, cially vascular tissues and amylin that is mainly produced and endothelium-derived hyperpolarizing factors. In ad- in the pancreas. They share some structural homology (ap- dition there are circulating agents; among these the most proximately 25–40%) and also some, but not total, similar- potent is 5-hydroxytryptamine. The neuronal messengers ities in biological activities (see Brain and Grant [11] for stored in the intracranial vessels have been reviewed recent review). CGRP is abundant in the body and has a (32) and it was revealed that sympathetic nerves store wide distribution throughout the central and peripheral noradrenaline, neuropeptide Y, and ATP, the parasympa- nervous systems.
  • Co-Regulation of Hormone Receptors, Neuropeptides, and Steroidogenic Enzymes 2 Across the Vertebrate Social Behavior Network 3 4 Brent M

    Co-Regulation of Hormone Receptors, Neuropeptides, and Steroidogenic Enzymes 2 Across the Vertebrate Social Behavior Network 3 4 Brent M

    bioRxiv preprint doi: https://doi.org/10.1101/435024; this version posted October 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Co-regulation of hormone receptors, neuropeptides, and steroidogenic enzymes 2 across the vertebrate social behavior network 3 4 Brent M. Horton1, T. Brandt Ryder2, Ignacio T. Moore3, Christopher N. 5 Balakrishnan4,* 6 1Millersville University, Department of Biology 7 2Smithsonian Conservation Biology Institute, Migratory Bird Center 8 3Virginia Tech, Department of Biological Sciences 9 4East Carolina University, Department of Biology 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 bioRxiv preprint doi: https://doi.org/10.1101/435024; this version posted October 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Running Title: Gene expression in the social behavior network 2 Keywords: dominance, systems biology, songbird, territoriality, genome 3 Corresponding Author: 4 Christopher Balakrishnan 5 East Carolina University 6 Department of Biology 7 Howell Science Complex 8 Greenville, NC, USA 27858 9 [email protected] 10 2 bioRxiv preprint doi: https://doi.org/10.1101/435024; this version posted October 4, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions

    Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions

    Molecular Pharmacology Fast Forward. Published on June 2, 2020 as DOI: 10.1124/mol.120.119388 This article has not been copyedited and formatted. The final version may differ from this version. File name: Opioid peptides v45 Date: 5/28/20 Review for Mol Pharm Special Issue celebrating 50 years of INRC Five decades of research on opioid peptides: Current knowledge and unanswered questions Lloyd D. Fricker1, Elyssa B. Margolis2, Ivone Gomes3, Lakshmi A. Devi3 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; E-mail: [email protected] 2Department of Neurology, UCSF Weill Institute for Neurosciences, 675 Nelson Rising Lane, San Francisco, CA 94143, USA; E-mail: [email protected] 3Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, Annenberg Downloaded from Building, One Gustave L. Levy Place, New York, NY 10029, USA; E-mail: [email protected] Running Title: Opioid peptides molpharm.aspetjournals.org Contact info for corresponding author(s): Lloyd Fricker, Ph.D. Department of Molecular Pharmacology Albert Einstein College of Medicine 1300 Morris Park Ave Bronx, NY 10461 Office: 718-430-4225 FAX: 718-430-8922 at ASPET Journals on October 1, 2021 Email: [email protected] Footnotes: The writing of the manuscript was funded in part by NIH grants DA008863 and NS026880 (to LAD) and AA026609 (to EBM). List of nonstandard abbreviations: ACTH Adrenocorticotrophic hormone AgRP Agouti-related peptide (AgRP) α-MSH Alpha-melanocyte stimulating hormone CART Cocaine- and amphetamine-regulated transcript CLIP Corticotropin-like intermediate lobe peptide DAMGO D-Ala2, N-MePhe4, Gly-ol]-enkephalin DOR Delta opioid receptor DPDPE [D-Pen2,D- Pen5]-enkephalin KOR Kappa opioid receptor MOR Mu opioid receptor PDYN Prodynorphin PENK Proenkephalin PET Positron-emission tomography PNOC Pronociceptin POMC Proopiomelanocortin 1 Molecular Pharmacology Fast Forward.
  • The Role of Corticotropin-Releasing Hormone at Peripheral Nociceptors: Implications for Pain Modulation

    The Role of Corticotropin-Releasing Hormone at Peripheral Nociceptors: Implications for Pain Modulation

    biomedicines Review The Role of Corticotropin-Releasing Hormone at Peripheral Nociceptors: Implications for Pain Modulation Haiyan Zheng 1, Ji Yeon Lim 1, Jae Young Seong 1 and Sun Wook Hwang 1,2,* 1 Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; [email protected] (H.Z.); [email protected] (J.Y.L.); [email protected] (J.Y.S.) 2 Department of Physiology, College of Medicine, Korea University, Seoul 02841, Korea * Correspondence: [email protected]; Tel.: +82-2-2286-1204; Fax: +82-2-925-5492 Received: 12 November 2020; Accepted: 15 December 2020; Published: 17 December 2020 Abstract: Peripheral nociceptors and their synaptic partners utilize neuropeptides for signal transmission. Such communication tunes the excitatory and inhibitory function of nociceptor-based circuits, eventually contributing to pain modulation. Corticotropin-releasing hormone (CRH) is the initiator hormone for the conventional hypothalamic-pituitary-adrenal axis, preparing our body for stress insults. Although knowledge of the expression and functional profiles of CRH and its receptors and the outcomes of their interactions has been actively accumulating for many brain regions, those for nociceptors are still under gradual investigation. Currently, based on the evidence of their expressions in nociceptors and their neighboring components, several hypotheses for possible pain modulations are emerging. Here we overview the historical attention to CRH and its receptors on the peripheral nociception and the recent increases in information regarding their roles in tuning pain signals. We also briefly contemplate the possibility that the stress-response paradigm can be locally intrapolated into intercellular communication that is driven by nociceptor neurons.
  • Stress Susceptibility-Specific Phenotype Associated with Different

    Stress Susceptibility-Specific Phenotype Associated with Different

    Lisowski et al. BMC Neuroscience 2013, 14:144 http://www.biomedcentral.com/1471-2202/14/144 RESEARCH ARTICLE Open Access Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice Pawel Lisowski1*, Grzegorz R Juszczak2, Joanna Goscik3, Adrian M Stankiewicz2, Marek Wieczorek4, Lech Zwierzchowski1 and Artur H Swiergiel5,6 Abstract Background: The effects of chronic treatment with tricyclic antidepressant (desipramine, DMI) on the hippocampal transcriptome in mice displaying high and low swim stress-induced analgesia (HA and LA lines) were studied. These mice displayed different depression-like behavioral responses to DMI: stress-sensitive HA animals responded to DMI, while LA animals did not. Results: To investigate the effects of DMI treatment on gene expression profiling, whole-genome Illumina Expres- sion BeadChip arrays and qPCR were used. Total RNA isolated from hippocampi was used. Expression profiling was then performed and data were analyzed bioinformatically to assess the influence of stress susceptibility-specific phe- notypes on hippocampal transcriptomic responses to chronic DMI. DMI treatment affected the expression of 71 genes in HA mice and 41 genes in LA mice. We observed the upregulation of Igf2 and the genes involved in neuro- genesis (HA: Sema3f, Ntng1, Gbx2, Efna5, and Rora; LA: Otx2, Rarb, and Drd1a) in both mouse lines. In HA mice, we observed the upregulation of genes involved in neurotransmitter transport, the termination of GABA and glycine ac- tivity (Slc6a11, Slc6a9), glutamate uptake (Slc17a6), and the downregulation of neuropeptide Y (Npy) and cortico- tropin releasing hormone-binding protein (Crhbp). In LA mice, we also observed the upregulation of other genes involved in neuroprotection (Ttr, Igfbp2, Prlr) and the downregulation of genes involved in calcium signaling and ion binding (Adcy1, Cckbr, Myl4, Slu7, Scrp1, Zfp330).